Cargando…
Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia
BACKGROUND: Neonatal hyperbilirubinemia (NHb) results from increased total serum bilirubin and is a common reason for admission and readmission amongst newborn infants born in North America. The use of intravenous immunoglobulin (IVIG) therapy for treating NHb has been widely debated, and the curren...
Autores principales: | Rasiah, Saisujani, Jegathesan, Thivia, Campbell, Douglas M., Shah, Prakeshkumar S., Sgro, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665189/ https://www.ncbi.nlm.nih.gov/pubmed/37491586 http://dx.doi.org/10.1038/s41390-023-02712-0 |
Ejemplares similares
-
Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels
por: Bhutani, Vinod K., et al.
Publicado: (2013) -
Tuberculosis Exposure from a Healthcare Worker to Patients in a Neonatal Intensive Care Unit (NICU)
por: Casalino, Maria, et al.
Publicado: (2022) -
Increasing clinical attendance among adolescents and young adults: a simple and novel method
por: Jegathesan, Thivia, et al.
Publicado: (2022) -
Evaluation of Intravenous Immunoglobulin Administration for Hyperbilirubinemia in Newborn Infants with Hemolytic Disease
por: Mohan, Daniel R., et al.
Publicado: (2023) -
School-based health care: improving academic outcomes for inner-city children—a prospective cohort quasi-experimental study
por: Rasiah, Saisujani, et al.
Publicado: (2023)